Witnessing the stock’s movement on the chart, on Thursday, Cns Pharmaceuticals Inc (NASDAQ: CNSP) set off with pace as it heaved 2.82% to $0.11, before settling in for the price of $0.11 at the close. Taking a more long-term approach, CNSP posted a 52-week range of $0.10-$137.50.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 0.00%. Meanwhile, its Annual Earning per share during the time was 17.98%. This publicly-traded company’s shares outstanding now amounts to $37.15 million, simultaneously with a float of $36.46 million. The organization now has a market capitalization sitting at $4.21 million. At the time of writing, stock’s 50-day Moving Average stood at $0.1347, while the 200-day Moving Average is $6.6650.
Cns Pharmaceuticals Inc (CNSP) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Cns Pharmaceuticals Inc’s current insider ownership accounts for 1.86%, in contrast to 0.39% institutional ownership. According to the most recent insider trade that took place on Feb 01 ’24, this organization’s Director bought 33,333 shares at the rate of 0.30, making the entire transaction reach 10,000 in total value, affecting insider ownership by 43,006. Preceding that transaction, on Feb 01 ’24, Company’s Director bought 33,333 for 0.30, making the whole transaction’s value amount to 10,000. This particular insider is now the holder of 33,458 in total.
Cns Pharmaceuticals Inc (NASDAQ: CNSP) Trading Performance Indicators
Let’s observe the current performance indicators for Cns Pharmaceuticals Inc (CNSP). It’s Quick Ratio in the last reported quarter now stands at 0.31. The Stock has managed to achieve an average true range (ATR) of 0.03.
In the same vein, CNSP’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -128.91, a figure that is expected to reach -0.10 in the next quarter, and analysts are predicting that it will be -0.85 at the market close of one year from today.
Technical Analysis of Cns Pharmaceuticals Inc (CNSP)
Going through the that latest performance of [Cns Pharmaceuticals Inc, CNSP]. Its last 5-days volume of 6.97 million indicated improvement to the volume of 5.35 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 17.07% While, its Average True Range was 0.0237.
Raw Stochastic average of Cns Pharmaceuticals Inc (CNSP) in the period of the previous 100 days is set at 0.45%, which indicates a major fall in contrast to 4.85% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 132.10% that was lower than 205.86% volatility it exhibited in the past 100-days period.
